GlassScriptPhysician profile
Donald Wayne Black
NPI 1528053220
$19,495.03
in general payments reported to CMS, 2019-2025
3 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $290 · 2020: $5,015 · 2021: $290 · 2022: $11K · 2023: $1,707 · 2024: $1,195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,820 · Food and Beverage: $82.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,820.00 |
| Food and Beverage | $82.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $12,570.03 | 2022-2024 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $4,725.00 | 2020 | |
| Merck Sharp & Dohme LLC | $2,200.00 | 2019-2024 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Black listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.